Guardian Pharmacy Services Lidocaine Syringe Recall: Non-Sterility Hazard
Guardian Pharmacy Services recalls 0.5 mL Lidocaine HCL/Sodium Bicarb syringes due to failed sterility test. Products with lot #50699:00 (expiring 10/04/16) may pose infection risks.
Lower-risk recall
Non-Sterility: failed sterility test result.
Contact the company
What happened, in plain English
Guardian Pharmacy Services is recalling certain Lidocaine HCL/Sodium Bicarb syringes because they failed a sterility test. This could lead to infections if used improperly. Read more at govinfonow.com/recall/42320-guardian-pharmacy-services-lidocaine-syringe-recall-non-sterility-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/42320-guardian-pharmacy-services-lidocaine-syringe-recall-non-sterility-hazard · Updated October 9, 2026 · FDA enforcement record: FDA #D-0211-2017
Cite this page
“Guardian Pharmacy Services Lidocaine Syringe Recall: Non-Sterility Hazard.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42320-guardian-pharmacy-services-lidocaine-syringe-recall-non-sterility-hazard. Based on FDA recall #D-0211-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0211-2017%22&limit=1).
Why it’s dangerous
The syringes failed a sterility test, meaning they may contain harmful bacteria or other contaminants. Using these syringes could lead to infections if the medication is injected.
Who’s affected
Patients prescribed this medication by a doctor who received the recalled syringes with lot number 50699:00 (expiring 10/04/16) are affected. Those using the product without medical supervision are not at risk.
How to tell if you have this one
Check for the lot number 50699:00 on the syringe packaging. The product expires on 10/04/16 and is a 0.5 mL pre-filled syringe for prescription use.
- Brand
Guardian Pharmacy Services- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 50699:00 on the syringe packaging to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed in Texas.
FDA distribution: “Two medical facilities in TX” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Texas.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0211-2017 (September 23, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0211-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.